[Macrophagic myofasciitis: description and etiopathogenic hypotheses. Study and Research Group on Acquired and Dysimmunity-related Muscular Diseases (GERMMAD) of the French Association against Myopathies (AFM)].
OBJECTIVE
A new type of inflammatory myopathy of unknown etiology has recently been described in France. The myopathy, called macrophagic myofasciitis, had never been described in the literature.


METHODS
In December 1998, 35 cases of macrophagic myofasciitis were reported, showing an increase in its incidence since the description of the first case in 1993. The first 22 cases are described.


RESULTS
The 22 patients were each referred with a presumptive diagnosis of either polymyositis (11 patients), polymyalgia rheumatica (5 patients), mitochondrial cytopathy (4 patients), or congenital myopathy or muscle dystrophy (1 patient for each). Clinical symptoms included myalgias (91%), arthralgias (68%), marked asthenia (55%), muscle weakness (45%), and fever (32%). Laboratory findings included elevated CK levels (50%) and a marked increased in the erythrocyte sedimentation rate (37%). Electromyographic recordings showed the existence of myopathy (35%). Muscle biopsy showed a unique pattern characterized by: (i) centripetal infiltration of the epimysium, perimysium and perifascicular endomysium by non epitheloid, cells of the monocyte/macrophage lineage (CD68+, CD1a-, S100-) with both large cytoplasm and PAS-positive content; (ii) absence of necrosis, of both epithelioid and giant cells, and of mitotic figures; (iii) occasional CD8+ T-cells; and, (iiii) minimal myocyte suffering. The disease symptoms were easily distinguishable from those of sarcoid myopathy and fasciitis-panniculitis syndromes. Infectious diseases known to be associated with reactive histiocytosis, including Whipple's disease, Mycobacterium avium intracellulare infection and malakoplakia, could not be documented. Patients' condition improved under corticosteroid therapy, associated or not with non-specific antibiotic therapy.


CONCLUSIONS
A new inflammatory muscle disorder of unknown etiology, characterized by a distinctive pathological pattern of macrophagic myofasciitis, is emerging in France. Diagnosis is based on muscular biopsy. Numerous clinical, epidemiological and etiopathologic studies initiated by the GERMMAD (Groupe d'études et de recherche sur les maladies musculaires acquises) are in progress.
Chérin
P
P
Service de médecine interne I, hôpital de la Pitié-Salpêtrière, Paris.
Laforet
P
P
Ghérardi
R K
RK
Authier
F J
FJ
Coquet
M
M
Maisonobe
T
T
Mussini
J M
JM
Pellissier
J F
JF
Herson
S
S
D000328:Adult; D000368:Aged; D001706:Biopsy; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000032:analysis; D003937:Diagnosis, Differential; D004576:Electromyography; D005205:Fascia / Q000473:pathology; D005208:Fasciitis / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005260:Female; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D015614:Histiocytosis / Q000175:diagnosis; D006801:Humans; D008264:Macrophages / Q000648:ultrastructure; D008279:Magnetic Resonance Imaging; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D009132:Muscles / Q000201:enzymology / Q000473:pathology; D009220:Myositis / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology
D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase
La myofasciite à macrophages: description, hypothèses étiopathogéniques. Groupe d'Etudes et de Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).